COSCIENS Biopharma Inc banner

COSCIENS Biopharma Inc
OTC:CSCID

Watchlist Manager
COSCIENS Biopharma Inc Logo
COSCIENS Biopharma Inc
OTC:CSCID
Watchlist
Price: 5 USD Market Closed
Market Cap: $15.9m

Wall St Price Targets

CSCID Price Targets Summary
COSCIENS Biopharma Inc

There are no price targets for CSCID.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
COSCIENS Biopharma Inc Competitors:
Price Targets
QLYS
Qualys Inc
-24% Downside
IDXX
IDEXX Laboratories Inc
30% Upside

Revenue
Forecast

10% / Year
Past Growth
-42% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
10% / Year
Past Growth
-42% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 1 year is -42%.

Gross Profit
Forecast

4% / Year
Past Growth
38% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
4% / Year
Past Growth
38% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 7 years is 38%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CSCID's stock price target?
Not Available

CSCID does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for COSCIENS Biopharma Inc?
Projected CAGR
-42%

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 1 year is -42%.

What is the Gross Profit forecast for COSCIENS Biopharma Inc?
Projected CAGR
38%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 7 years is 38%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett